FIGS Bundle
How does FIGS operate?
FIGS, Inc. has redefined the healthcare apparel industry with its direct-to-consumer model, offering stylish and functional medical wear. The company achieved a trailing twelve-month revenue of $569.58 million as of June 30, 2025.
This innovative approach targets healthcare professionals seeking comfort and style, contributing to a market capitalization of $1.12 billion as of August 14, 2025. The company's success is built on a foundation of strong brand identity and digital engagement.
FIGS primarily generates revenue through the sale of its premium medical apparel, including its popular FIGS PESTEL Analysis. Its direct-to-consumer strategy bypasses traditional retail channels, allowing for greater control over brand messaging and customer experience. This model has fostered a loyal customer base, reaching 2.74 million active customers in Q2 2025.
What Are the Key Operations Driving FIGS’s Success?
The FIGS company operations are designed to deliver high-quality medical apparel that enhances the comfort and style of healthcare professionals. Their core business revolves around creating technically advanced scrubs and a variety of other apparel items, all with a focus on improving the daily work experience for their target customer. This approach differentiates them significantly in the medical uniform market.
Core Value Proposition
FIGS provides healthcare professionals with technically advanced, comfortable, functional, and stylish apparel. Their value proposition centers on elevating the daily work experience for these professionals through superior product design and premium materials.
Direct-to-Consumer Model
The FIGS business model is primarily direct-to-consumer (DTC), utilizing their e-commerce platform and mobile app. This allows for higher margins, direct customer feedback, and continuous product innovation.
Product Innovation and Materials
FIGS sources premium materials for proprietary fabric blends, offering features like anti-microbial properties, wrinkle resistance, and four-way stretch. This focus on material science is key to their product differentiation.
Logistics and Infrastructure
Efficient logistics are crucial to how FIGS works, supported by infrastructure like their expanded distribution center moved into in 2024. This facility is designed to enhance operational efficiency and manage increased order volumes.
Brand Identity and Community Engagement
FIGS cultivates a strong brand identity that fosters a sense of community and pride among healthcare professionals. Their marketing efforts, such as achieving approximately 900 million impressions during Nurses Week in 2025, highlight this focus.
- Performance apparel meets fashion-forward aesthetics.
- Direct delivery to a specific professional community.
- Robust digital marketing and community engagement strategies.
- Strong brand loyalty and word-of-mouth referrals.
- Significant social media engagement, with film views up 10x and social engagement up 5x year-over-year in 2025.
The operational effectiveness of the FIGS company is amplified by its integrated approach, combining product innovation with strong digital marketing and community building. This strategy ensures that their core capabilities, such as superior comfort and style in their apparel, translate into tangible customer benefits and significant market differentiation. Understanding the Competitors Landscape of FIGS helps to contextualize their unique position in the market.
FIGS SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Does FIGS Make Money?
The primary revenue for the company is generated through the direct sale of healthcare apparel and lifestyle products, with scrubwear sales forming the largest portion. In the second quarter of 2025, scrubwear net revenues accounted for 83% of total sales, reaching $127.4 million. This segment saw an 8% increase year-over-year, underscoring its importance to the FIGS business model.
Scrubwear Dominance
Scrubwear is the core revenue driver, representing a significant majority of sales. This focus highlights the company's deep penetration within the healthcare apparel market.
Non-Scrubwear Performance
Non-scrubwear items, including outerwear and footwear, experienced a slight decrease in Q2 2025. This dip was attributed to promotional activities and external cost pressures.
Overall Revenue Growth
For the entirety of 2024, the company reported net revenues of $555.6 million. The first quarter of 2025 saw net revenues climb to $124.9 million, a 4.7% increase from the previous year.
Average Order Value
A key metric for FIGS company operations is the average order value (AOV), which rose to $119 in Q1 2025 and $117 in Q2 2025. This indicates a growing customer spend per transaction.
Premium Pricing Strategy
The monetization strategy centers on a premium pricing model, aiming to preserve brand equity by minimizing heavy discounting. This approach contributed to a gross margin of 67.0% in Q2 2025.
International Expansion
International net revenues showed robust growth, increasing by 19.8% year-over-year to $22.7 million in Q2 2025. This segment now represents 15% of the company's total revenue.
Diversification and B2B Growth
Beyond direct-to-consumer sales, the company is actively pursuing diversification through its institutional-focused TEAMS program. This B2B channel targets healthcare institutions for bulk purchases and custom branding, aiming to tap into new customer segments and further solidify the FIGS business model.
- Direct sales of healthcare apparel and lifestyle products.
- Scrubwear sales as the primary revenue generator.
- Non-scrubwear sales contributing to overall revenue.
- Premium pricing strategy to enhance brand value.
- International market expansion driving revenue growth.
- TEAMS program for institutional B2B sales.
FIGS PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Which Strategic Decisions Have Shaped FIGS’s Business Model?
The company's journey is marked by significant achievements, including the 2013 launch of its direct-to-consumer model, which revolutionized the medical apparel sector. This digitally-native approach, coupled with a focus on proprietary fabric technology and ergonomic design, has been central to its success. A key strategic move in 2024 involved relocating to a larger distribution center to boost operational efficiency and support its ambitious revenue targets.
Direct-to-Consumer Disruption
Launched in 2013, the direct-to-consumer model offered a premium, digitally-native experience, fundamentally changing the medical uniform industry.
Product Innovation Focus
Consistent innovation in proprietary fabric technology and ergonomic design has been a core element of the company's appeal and product differentiation.
Strategic Operational Enhancements
In 2024, a significant move was the relocation to a larger distribution center, designed to improve operational efficiency and accommodate future growth plans.
Navigating Market Challenges
The company has addressed challenges like rising acquisition costs and tariff impacts through supply chain flexibility and strategic supplier negotiations.
The company's competitive edge is built on several pillars, including a strong brand identity and active community engagement, fostering a loyal customer base with 2.74 million active customers as of Q2 2025. Technological leadership in fabric development provides a superior product experience, while its agile direct-to-consumer ecosystem allows for rapid feedback integration and market responsiveness. This approach differentiates it from traditional apparel companies. The company continues to adapt by investing in international market entries, such as Japan and South Korea in 2025, and expanding its B2B presence through the TEAMS program, demonstrating a commitment to sustained growth amidst evolving trends and competitive pressures. This focus on brand equity and strategic expansion is a key part of the Marketing Strategy of FIGS.
Key Competitive Advantages
The company's competitive advantages stem from its strong brand loyalty, technological innovation in fabrics, and an agile direct-to-consumer operational model.
- Strong brand strength and community engagement
- Technology leadership in fabric innovation
- Agile direct-to-consumer ecosystem for rapid feedback
- Strategic international expansion and B2B growth
FIGS Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
How Is FIGS Positioning Itself for Continued Success?
FIGS has established a strong presence in the healthcare apparel sector, differentiating itself through a direct-to-consumer approach. The company's annual revenue reached $555.6 million in 2024, positioning it significantly within the global market. This success is built on customer loyalty fostered by product quality, comfort, and style, supported by operations in 32 countries.
Industry Position
FIGS operates as a key player in the healthcare apparel market, competing with brands like Jaanuu and WonderWink. Its direct-to-consumer strategy has been a significant differentiator, allowing it to capture a notable share of the estimated $79 billion global market. The company's focus on quality and design has cultivated a loyal customer base.
Key Risks and Headwinds
Several factors present potential challenges for FIGS, including ongoing tariff uncertainties that are projected to impact the company by approximately 150 basis points in 2025. Changes in promotional strategies could affect customer acquisition, and growth in the domestic market may slow compared to international expansion efforts.
Future Outlook and Strategy
The company anticipates low-single-digit net revenue growth for the full year 2025, with an adjusted EBITDA margin projected between 8.5% and 9.0%. Strategic initiatives are in place to enhance profitability and expand market reach.
Strategic Priorities
FIGS is prioritizing international expansion, with plans to launch in Japan and South Korea in 2025. The company is also bolstering its B2B TEAMS program by appointing a dedicated leader and developing an outbound sales team to target institutional clients. This approach aims to maintain brand equity and operational efficiency.
Growth and Market Penetration
FIGS is focusing on expanding its global footprint and strengthening its B2B segment. The company's commitment to its direct-to-consumer model, coupled with strategic international growth and B2B program development, underpins its strategy for sustained profitability and market leadership.
- International expansion into Japan and South Korea in 2025.
- Strengthening the B2B TEAMS program with dedicated leadership.
- Building an outbound sales function for institutional market penetration.
- Prioritizing brand equity over deep discounting.
- Focusing on operational efficiencies to maintain profitability.
FIGS Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of FIGS Company?
- What is Competitive Landscape of FIGS Company?
- What is Growth Strategy and Future Prospects of FIGS Company?
- What is Sales and Marketing Strategy of FIGS Company?
- What are Mission Vision & Core Values of FIGS Company?
- Who Owns FIGS Company?
- What is Customer Demographics and Target Market of FIGS Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.